Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ritchlin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Arthritis Research|November 30, 2000
Fibroblast biology. Effector signals released by the synovial fibroblast in arthritisC Ritchlin
Clinical and Experimental Rheumatology|March 1, 1993
Alteration of synoviocytes by inflammation--the source of a persistent non-immunologic drive in synovitis: analysis of levels of mRNA expression by a simple multi-gene assayR Winchester, F Su, C Ritchlin
The Journal of Rheumatology|May 1, 2001
Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cellsC Ritchlin, S A Haas-Smith
Clinical and Experimental Rheumatology|November 29, 2007
Quality indicators in psoriatic arthritisA Kavanaugh, C Ritchlin, W-H Boehncke
Annals of the Rheumatic Diseases|February 15, 2005
Immunopathology of psoriasis and psoriatic arthritisD J Veale, C Ritchlin, O FitzGerald
The Journal of Experimental Medicine|March 1, 1991
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblastsR Bucala, C Ritchlin, R Winchester, et al.
Scandinavian Journal of Immunology|September 1, 1994
Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitisC Ritchlin, E Dwyer, R Bucala, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Psoriatic arthritis clinical registries and genomicsD D Gladman, C Ritchlin, P S Helliwell
The Journal of Rheumatology|August 1, 1992
Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumoniaA J Porges, S L Beattie, C Ritchlin, et al.
Archives of Dermatology|July 17, 2001
Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion proteinR Zeltser, L Valle, C Tanck, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Arthritis Research|November 30, 2000
Fibroblast biology. Effector signals released by the synovial fibroblast in arthritisC Ritchlin
Clinical and Experimental Rheumatology|March 1, 1993
Alteration of synoviocytes by inflammation--the source of a persistent non-immunologic drive in synovitis: analysis of levels of mRNA expression by a simple multi-gene assayR Winchester, F Su, C Ritchlin
The Journal of Rheumatology|May 1, 2001
Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cellsC Ritchlin, S A Haas-Smith
Clinical and Experimental Rheumatology|November 29, 2007
Quality indicators in psoriatic arthritisA Kavanaugh, C Ritchlin, W-H Boehncke
Annals of the Rheumatic Diseases|February 15, 2005
Immunopathology of psoriasis and psoriatic arthritisD J Veale, C Ritchlin, O FitzGerald
The Journal of Experimental Medicine|March 1, 1991
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblastsR Bucala, C Ritchlin, R Winchester, et al.
Scandinavian Journal of Immunology|September 1, 1994
Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitisC Ritchlin, E Dwyer, R Bucala, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Psoriatic arthritis clinical registries and genomicsD D Gladman, C Ritchlin, P S Helliwell
The Journal of Rheumatology|August 1, 1992
Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumoniaA J Porges, S L Beattie, C Ritchlin, et al.
Archives of Dermatology|July 17, 2001
Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion proteinR Zeltser, L Valle, C Tanck, et al.
Pageof 2